Bristol Myers (BMY) announces FDA approves Nivolumab with chemotherapy for previously untreated hodgkin lymphoma
Every headline is on the live feed 20 minutes before this site.
Italy 5-year CDS rises 4.7bps, highest since October; UK 5-year CDS rise 2.4bps to 20.5bps, highest since October; France 5-year CDS rise 3.8bps to 31.6bps; highest since November
Switzerland has removed seven people from the list of sanctions against Russia, according to reports
Bristol Myers (BMY) announces FDA approves Nivolumab with chemotherapy for previously untreated hodgkin lymphoma
IRGC HQ targeted in Tabriz
Netflix (NFLX) and Warner Music (WMG) sign multi-year documentary partnership
On the Newsquawk feed at , 20 minutes before this page.
Context
Bristol Myers' approval of Nivolumab for treating previously untreated Hodgkin lymphoma is a significant milestone that could boost the company's oncology portfolio. This FDA approval enhances BMY's product offerings and may positively impact its share price due to increased expectations of revenue growth in the oncology segment. Traders should consider the potential market reaction, not only for BMY but also for competitors in the oncology space, as this sets a strong precedent for future approvals in similar therapeutics.
Related headlines
- US BROKER MOVES: CPRI upgrade at Raymond James; WDAY downgraded at KeyBanc1 day ago
- US Market Wrap: Stocks hit as AI growth concerns weigh on sentiment 16 hours ago
- Newsquawk Daily European Equity Opening News - 16th October 20261 day ago
- Weekly US Earnings Estimates: 19th-23rd October 2026: Earnings pick up with META, TSLA, SPCX, LRCX, and NFLX the highlights16 hours ago
- Daily US Equity Opening News: 16th October 2026: TSLA gains on Roadster reveal; NFLX slips as Content Chief to leave; TRV earnings underwhelm23 hours ago
- Nvidia (NVDA) expands tools for building AI-powered games with Unreal Engine 517 hours ago
- US FAA is set to approve certification for the Boeing (BA) 737 MAX 10, sources report; potentially as soon as in the next week18 hours ago
- Daily US Earnings Estimates: 19th October 2026: FITB, WRB, and STLD20 hours ago
- US officials pressed Beijing on market access issues for Mastercard (MA) and Citigroup (C) during at least two bilateral meetings with Chinese counterparts in Bangkok this week, CNBC reports, citing a source20 hours ago
- Apple (AAPL) set for UK legal fight over iPhone tap-to-pay rules, FT reports21 hours ago
- US EQUITY OPEN: Stocks mixed at the open as AI stock rout continues22 hours ago
- US DoJ officials have reportedly signalled their preference to settle antitrust lawsuit against Apple (AAPL), The Information reports citing sources23 hours ago
- US PREMARKET MOVERS: TSLA, NFLX, VRNS, AA, TRV, MSTR, WDAY, ECHO1 day ago
- Charles Schwab (SCHW) CEO says seeing record levels of interest in fixed income; Brokerage is blocking unauthorised AI agents1 day ago
- Apple (AAPL) iPhone duo delivery date slips to January 25th1 day ago
- Apple's (AAPL) iPhone Duo sells out minutes after pre-orders open, according to Apple Insider1 day ago
- ExxonMobil (XOM) says changes in margins to impact Q3 chemical products earnings by USD -0.6bln Q/Q1 day ago
- Nvidia's (NVDA) RTX Spark laptops have launched globally, starting at USD 2,5991 day ago
- Travelers (TRV) Q3 2026 (USD): Adj. EPS 9.18 (exp. 7.39), Revenue 12.4bln (exp. 11.4bln); Net Premiums Written 11.48bln (exp. 11.40bln), Catastrophe Loss 538mln (exp. 695mln)1 day ago
- Truist Financial (TFC) Q3 2026 (USD): EPS 1.16 (exp. 1.14), Revenue 3.79bln (exp. 5.35bln)1 day ago
The feed had this first.
Use the Platform